GB9005498D0
(en)
*
|
1990-03-12 |
1990-05-09 |
Beecham Group Plc |
Composition
|
US5162110A
(en)
*
|
1990-12-19 |
1992-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Binding theophylline to ion exchange resins
|
WO1992011038A1
(en)
*
|
1990-12-21 |
1992-07-09 |
Richardson-Vicks Inc. |
Polyamine drug-resin complexes
|
US5275820A
(en)
*
|
1990-12-27 |
1994-01-04 |
Allergan, Inc. |
Stable suspension formulations of bioerodible polymer matrix microparticles incorporating drug loaded ion exchange resin particles
|
US5273758A
(en)
*
|
1991-03-18 |
1993-12-28 |
Sandoz Ltd. |
Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
|
US5486362A
(en)
*
|
1991-05-07 |
1996-01-23 |
Dynagen, Inc. |
Controlled, sustained release delivery system for treating drug dependency
|
US5403595A
(en)
*
|
1991-05-07 |
1995-04-04 |
Dynagen, Inc. |
Controlled, sustained release delivery system for smoking cessation
|
IT1250736B
(it)
*
|
1991-08-01 |
1995-04-21 |
Zambon Spa |
Processo per la preparazione dell'acido 5-(2',4'-difluorofenil) salicilico in forma ii pura
|
SE9103110D0
(sv)
|
1991-10-24 |
1991-10-24 |
Kabi Pharmacia Ab |
New drug formulation
|
US5492700A
(en)
*
|
1991-11-26 |
1996-02-20 |
Warner-Lambert Company |
Process and composition for the development of controlled release gemfibrozil dosage form
|
IT1252185B
(it)
*
|
1991-12-11 |
1995-06-05 |
Therapicon Srl |
Preparazioni farmaceutiche a liberazione programmata
|
US5260066A
(en)
*
|
1992-01-16 |
1993-11-09 |
Srchem Incorporated |
Cryogel bandage containing therapeutic agent
|
US5296228A
(en)
*
|
1992-03-13 |
1994-03-22 |
Allergan, Inc. |
Compositions for controlled delivery of pharmaceutical compounds
|
CA2063499C
(en)
*
|
1992-03-19 |
1996-06-18 |
Leon Edward St. Pierre |
Ingestible polymeric phosphonium salts for the lowering of blood cholesterol
|
US5780051A
(en)
*
|
1992-04-02 |
1998-07-14 |
Dynagen, Inc. |
Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
|
JP3278192B2
(ja)
*
|
1992-04-03 |
2002-04-30 |
ロート製薬株式会社 |
徐放性液剤
|
TW237386B
(de)
*
|
1992-04-15 |
1995-01-01 |
Ciba Geigy |
|
SE9202250D0
(sv)
*
|
1992-07-29 |
1992-07-29 |
Gacell Lab Ab |
Controlled release morphine preparation
|
EP1016673B1
(de)
*
|
1992-10-02 |
2006-02-01 |
Genetics Institute, LLC |
Zusammensetzung, welche den Koagulationsfaktor VIII beinhalted; Verfahren zu deren Herstellung und die Benutzung eines Oberflächenaktiven Stoffes als Stabilisator
|
CA2148465C
(en)
*
|
1992-11-06 |
1999-11-02 |
Minenobu Okayama |
Oral pharmaceutical preparation releasable in the lower digestive tract
|
USRE39300E1
(en)
|
1993-01-28 |
2006-09-19 |
Virginia Commonwealth University Medical College Of Virginia |
Inhibiting the development of tolerance to and/or dependence on an addictive substance
|
US5321012A
(en)
*
|
1993-01-28 |
1994-06-14 |
Virginia Commonwealth University Medical College |
Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
|
ATE181672T1
(de)
*
|
1993-04-28 |
1999-07-15 |
Takeda Chemical Industries Ltd |
Geschmacksmaskierte feste zubereitung und verfahren zur herstellung
|
ZA944949B
(en)
*
|
1993-07-12 |
1995-04-05 |
Smithkline Beecham Corp |
Matrix-entrapped beadlet preparation
|
EP0664699A1
(de)
*
|
1993-08-13 |
1995-08-02 |
Vitaphore Corporation |
Arzneimittelabgabesystem auf der Basis von Hydrogelmikrokugeln
|
CA2176933A1
(en)
*
|
1993-11-18 |
1995-05-26 |
Yan Chen |
Controlled release preparation
|
DE4402379C2
(de)
*
|
1994-01-27 |
1997-09-25 |
Lohmann Therapie Syst Lts |
Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung
|
US6322815B1
(en)
|
1994-07-22 |
2001-11-27 |
W. Mark Saltzman |
Multipart drug delivery system
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
US6413539B1
(en)
*
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
GB9607955D0
(en)
*
|
1996-04-17 |
1996-06-19 |
Tillotts Pharma Ag |
Hydrophobic carbomer salt compositions
|
ATE406872T1
(de)
*
|
1996-12-20 |
2008-09-15 |
Mcneil Ppc Inc |
Durch ionenaustauscherharze verabreichte hustenmittel
|
US5980882A
(en)
*
|
1997-04-16 |
1999-11-09 |
Medeva Pharmaceuticals Manufacturing |
Drug-resin complexes stabilized by chelating agents
|
CA2355829A1
(en)
*
|
1999-01-07 |
2000-07-13 |
Louise Templeton |
Multiparticulate oral dosage forms
|
ES2313897T3
(es)
*
|
1999-07-14 |
2009-03-16 |
Schering-Plough Ltd. |
Enmascaramiento del sabor de prepararciones liquidas de quinologia orales usando resinas de intercambio ionico.
|
EP2269587A1
(de)
|
1999-10-29 |
2011-01-05 |
Euro-Celtique S.A. |
Hydrocodon-Formulierungen mit gesteuerter Freisetzung
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US7067116B1
(en)
*
|
2000-03-23 |
2006-06-27 |
Warner-Lambert Company Llc |
Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
|
US6855721B1
(en)
|
2000-07-28 |
2005-02-15 |
Indevus Pharmaceuticals, Inc. |
Methods and compositions for alleviating stuttering
|
AU2738302A
(en)
|
2000-10-30 |
2002-05-15 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
WO2002036077A2
(en)
*
|
2000-11-06 |
2002-05-10 |
Andrx Pharmaceuticals, Inc. |
Once a day antihistamine and decongestant formulation
|
US20060198815A1
(en)
*
|
2001-03-19 |
2006-09-07 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained release
|
US20020176841A1
(en)
*
|
2001-03-19 |
2002-11-28 |
Praecis Pharmaceuticals Inc. |
Pharmaceutical formulations for sustained release
|
US6623754B2
(en)
*
|
2001-05-21 |
2003-09-23 |
Noveon Ip Holdings Corp. |
Dosage form of N-acetyl cysteine
|
EP1429728A1
(de)
*
|
2001-08-29 |
2004-06-23 |
SRL Technologies, Inc. |
Zubereitungen mit verzögerter freisetzung
|
JP2005509648A
(ja)
*
|
2001-11-09 |
2005-04-14 |
ローレン チャロウス、 |
炎症性腸疾患の治療方法
|
CA2481091A1
(en)
*
|
2002-04-05 |
2003-10-23 |
Penwest Pharmaceuticals Co. |
Sustained release metoprolol formulations
|
US7125563B2
(en)
*
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
CA2498798A1
(en)
*
|
2002-09-20 |
2004-04-01 |
Alpharma, Inc. |
Sustained-release opioid formulations and methods of use
|
US8092831B2
(en)
*
|
2002-11-08 |
2012-01-10 |
Andrx Pharmaceuticals, Llc |
Antihistamine and decongestant system
|
US20050013792A1
(en)
*
|
2002-11-26 |
2005-01-20 |
Hollenbeck Gary R. |
Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs
|
JP2006515008A
(ja)
*
|
2003-01-28 |
2006-05-18 |
コレギウム ファーマシューティカル, インコーポレイテッド |
経口投与のためのミルナシプランの多粒子状組成物
|
US20050152967A1
(en)
*
|
2003-03-28 |
2005-07-14 |
Pfab, Lp |
Dynamic variable release
|
US7314640B2
(en)
*
|
2003-07-11 |
2008-01-01 |
Mongkol Sriwongjanya |
Formulation and process for drug loaded cores
|
WO2005013934A2
(en)
*
|
2003-07-28 |
2005-02-17 |
Novartis Consumer Health S.A. |
Taste-masked composition of cationic exchange resin
|
CN1845722A
(zh)
*
|
2003-09-03 |
2006-10-11 |
马林克罗特公司 |
粒状缓释制剂及其生产
|
EP1708684A2
(de)
|
2003-09-26 |
2006-10-11 |
Alza Corporation |
Arzneimittelbeschichtung mit hoher arzneimittelbeladung und verfahren dafür
|
US7387793B2
(en)
*
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
US20050142097A1
(en)
*
|
2003-12-29 |
2005-06-30 |
Deepak Thassu |
Multiple active drug resin conjugate
|
WO2007001300A1
(en)
*
|
2005-06-28 |
2007-01-04 |
Ucb, S.A. |
Multiple active drug-resin conjugate
|
US20070232695A1
(en)
*
|
2004-01-28 |
2007-10-04 |
Collegium Pharmaceutical, Inc. |
Gelled Periodontal Anesthetic Preparation
|
US20050181050A1
(en)
*
|
2004-01-28 |
2005-08-18 |
Collegium Pharmaceutical, Inc. |
Dosage forms using drug-loaded ion exchange resins
|
US20050226920A1
(en)
*
|
2004-04-13 |
2005-10-13 |
Kirk Voelker |
Method of decreasing nicotine withdrawal symptoms during smoking cessation.
|
EP1744740A4
(de)
|
2004-04-27 |
2009-06-17 |
Medicinova Inc |
Phenoxyalkylcarbonsäurederivat bei der behandlung von entzündlichen erkrankungen
|
JP4805256B2
(ja)
*
|
2004-05-14 |
2011-11-02 |
グリーン・クロス・コーポレイション |
右旋性モルヒナンの神経保護特性
|
US20050255048A1
(en)
*
|
2004-05-15 |
2005-11-17 |
Collegium Pharmaceutical, Inc. |
Sprayable formulations for the treatment of acute inflammatory skin conditions
|
US20050265955A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Mallinckrodt Inc. |
Sustained release preparations
|
US9308164B2
(en)
*
|
2004-06-30 |
2016-04-12 |
Sovereign Pharmaceuticals, Llc |
Hyoscyamine dosage form
|
WO2006101536A1
(en)
*
|
2004-11-04 |
2006-09-28 |
Akina, Inc. |
Fast-melting tablets having taste-masking and sustained release properties
|
US20070036843A1
(en)
*
|
2005-01-28 |
2007-02-15 |
Collegium Pharmaceutical, Inc. |
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
|
EP1893175A1
(de)
*
|
2005-06-09 |
2008-03-05 |
Upm Pharmaceuticals, Inc. |
Wässriges arzneistoffabgabesystem mit anhaltender wirkstofffreigabe für stark wasserlösliche elektrolytika
|
US8343546B2
(en)
*
|
2005-09-13 |
2013-01-01 |
Coating Place, Inc. |
Ion exchange resin treated to control swelling
|
EP1926736A4
(de)
*
|
2005-09-21 |
2010-08-25 |
Chong Kun Dang Pharm Corp |
Neuer resinat-komplex von s-clopidogrel und verfahren zu dessen herstellung
|
US20070141147A1
(en)
*
|
2005-12-21 |
2007-06-21 |
Auriga Laboratories, Inc. |
Sequential release pharmaceutical formulations
|
CA2645855C
(en)
*
|
2006-03-16 |
2015-02-03 |
Tris Pharma, Inc. |
Modified release formulations containing drug-ion exchange resin complexes
|
WO2007117581A2
(en)
*
|
2006-04-06 |
2007-10-18 |
Collegium Pharmaceutical, Inc. |
Stabilized transdermal bupropion preparations
|
US20070286903A1
(en)
*
|
2006-06-13 |
2007-12-13 |
Becicka Brian T |
Composition and method for taste masking
|
US20080064694A1
(en)
*
|
2006-09-11 |
2008-03-13 |
Auriga Laboratories, Inc. |
Multi-Phase Release Methscopolamine Compositions
|
US20080069874A1
(en)
*
|
2006-09-15 |
2008-03-20 |
Auriga Laboratories, Inc. |
Kits for Prevention and Treatment of Rhinitis
|
US20080085312A1
(en)
*
|
2006-10-04 |
2008-04-10 |
Auriga Laboratories, Inc. |
Multi-Phase Release Potassium Guaiacolsulfonate Compositions
|
US20080207593A1
(en)
*
|
2007-02-28 |
2008-08-28 |
Collegium Pharmaceutical, Inc. |
Antihistamine Combination
|
US8202542B1
(en)
|
2007-05-31 |
2012-06-19 |
Tris Pharma |
Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
|
CN101801350A
(zh)
*
|
2007-08-13 |
2010-08-11 |
阿巴斯迪特宁医药有限公司 |
抗滥用药物、使用方法和制备方法
|
ES2537622T3
(es)
*
|
2008-09-24 |
2015-06-10 |
Evonik Röhm Gmbh |
Composición farmacéutica de liberación controlada dependiente del pH para compuestos no opioides con resistencia frente a la influencia del etanol
|
WO2010133961A1
(en)
|
2009-05-22 |
2010-11-25 |
Inventia Healthcare Private Limited |
Extended release compositions of cyclobenzaprine
|
AU2010337856A1
(en)
*
|
2009-12-31 |
2012-07-19 |
Ranbaxy Laboratories Limited |
Taste masked dosage forms of bitter tasting anti-retroviral drugs
|
US8470375B1
(en)
|
2010-01-05 |
2013-06-25 |
Neos Therapeutics, Lp |
Method of formulating and designing liquid drug suspensions containing ion exchange resin particles
|
WO2012042314A1
(en)
|
2010-10-02 |
2012-04-05 |
Link Research & Grants Corporation |
Treatment of tinnitus and related auditory dysfunctions
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
US20130230587A1
(en)
|
2010-11-10 |
2013-09-05 |
Rubicon Research Private Limited |
Sustained release compositions
|
US8287903B2
(en)
|
2011-02-15 |
2012-10-16 |
Tris Pharma Inc |
Orally effective methylphenidate extended release powder and aqueous suspension product
|
WO2013003622A1
(en)
|
2011-06-28 |
2013-01-03 |
Neos Therapeutics, Lp |
Dosage forms for oral administration and methods of treatment using the same
|
WO2013070656A1
(en)
*
|
2011-11-07 |
2013-05-16 |
Navinta Llc |
Sustained release suspension preparation for dextromethorphan
|
US8962687B2
(en)
|
2012-12-05 |
2015-02-24 |
Medicinova, Inc. |
Method of treating liver disorders
|
JP2013119550A
(ja)
|
2011-12-08 |
2013-06-17 |
Medicinova Inc |
非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法
|
EP2833868A1
(de)
|
2011-12-09 |
2015-02-11 |
Wockhardt Limited |
Orales flüssiges konzentrat mit brompheniramin, pseudoephedrin und dextromethorphan
|
WO2013088271A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Modified release liquid pharmaceutical composition comprising bromopheniramine, pseudoephedrine and dextromethorphan
|
ES2717469T3
(es)
|
2012-08-15 |
2019-06-21 |
Tris Pharma Inc |
Comprimido masticable de metilfenidato de liberación prolongada
|
RU2015131034A
(ru)
*
|
2013-01-15 |
2017-02-01 |
Сан Фармасьютикал Индастрис Лтд. |
Устойчивая композиция, содержащая финголимод
|
WO2014146093A2
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
BR112016001400B1
(pt)
|
2013-07-25 |
2023-02-28 |
Medicinova, Inc |
Uso de ácidos fenoxialquilcarboxílicos para preparação de medicamentos para a redução de níveis sanguíneos de triglicerídeos, colesterol total e lipoproteínas de baixa densidade
|
US9770514B2
(en)
|
2013-09-03 |
2017-09-26 |
ExxPharma Therapeutics LLC |
Tamper-resistant pharmaceutical dosage forms
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
WO2015076821A1
(en)
*
|
2013-11-22 |
2015-05-28 |
Tris Pharma, Inc. |
Novel clonidine formulation
|
US20150321989A1
(en)
|
2014-05-08 |
2015-11-12 |
Medicinova, Inc. |
Method of treating idiopathic pulmonary fibrosis
|
US9346754B2
(en)
|
2014-05-08 |
2016-05-24 |
Medicinova, Inc. |
Method of treating advanced non-alcoholic steatohepatitis
|
ES2957213T3
(es)
|
2014-06-02 |
2024-01-15 |
Medicinova Inc |
Método para inhibir o tratar la fibrosis
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
US10258611B2
(en)
|
2014-11-26 |
2019-04-16 |
Medicinova, Inc. |
Combination of ibudilast and riluzole and methods of using same
|
MA41152A
(fr)
*
|
2014-12-12 |
2017-10-17 |
Johnson & Johnson Consumer Inc |
Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
EP3503879A4
(de)
|
2016-08-26 |
2020-04-29 |
EXCIVA GmbH |
Zusammensetzung und verfahren dafür
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
EP3740189A1
(de)
|
2017-12-18 |
2020-11-25 |
Tris Pharma, Inc. |
Arzneimittelpulverzusammensetzung mit modifizierter freisetzung mit gastro-retentiven raft-bildenden systemen mit triggerimpuls-arzneimittelfreisetzung
|
WO2019126214A1
(en)
|
2017-12-18 |
2019-06-27 |
Tris Pharma, Inc. |
Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
|
WO2019126215A1
(en)
|
2017-12-18 |
2019-06-27 |
Tris Pharma, Inc. |
Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
|
CN111971029A
(zh)
*
|
2017-12-22 |
2020-11-20 |
Ddp特种电子材料美国公司 |
含有交联的离子交换树脂的药物组合物
|
US20210077402A1
(en)
*
|
2017-12-22 |
2021-03-18 |
Dow Global Technologies, Llc |
Pharmaceutical composition containing resin particles
|
US11918689B1
(en)
|
2020-07-28 |
2024-03-05 |
Tris Pharma Inc |
Liquid clonidine extended release composition
|
EP4346783A1
(de)
|
2021-05-28 |
2024-04-10 |
MediciNova, Inc. |
Phenoxyalkylcarbonsäurederivate und ihre verwendung zur senkung des triglyceridspiegels
|